1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Sherlock Biosciences Acquires Sense Biodetection

M&A Deal Summary

Sherlock Biosciences Acquires Sense Biodetection

On February 1, 2023, Sherlock Biosciences acquired life science company Sense Biodetection

Acquisition Highlights
  • This is Sherlock Biosciences’ 1st transaction in the Life Science sector.
  • This is Sherlock Biosciences’ 1st transaction in the United States.
  • This is Sherlock Biosciences’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2023-02-01
Target Sense Biodetection
Sector Life Science
Buyer(s) Sherlock Biosciences
Deal Type Add-on Acquisition

Target

Sense Biodetection

Milford, Massachusetts, United States
Sense Biodetection is a global molecular diagnostics company focused on empowering patients and transforming healthcare access and affordability by bringing lab-quality results through easy-to-use, rapid, disposable molecular tests without the constraints of an instrument. Sense Biodetection is based in Milford, Massachusetts.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sherlock Biosciences

Watertown, Massachusetts, United States
Category Company
Sector Life Science
DESCRIPTION

Sherlock Biosciences is developing products that will empower people to access answers and have more control over their health decisions. Sherlock Biosciences is based in Watertown, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal